This reflects the innate heterogeneity and plasticity of patient breast cancer tissues and also is consistent with the significant cell type-specificity of the influence of CtBP inhibition, mentioned previously (Fig. 4), and observed in CtBP-depleted cell lines14. The gene discussed is CTBP1; the disease is breast carcinoma.